Vyrexip Holdings, Inc.
Records under this name other than patents Vyrexip Holdings, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Vyrexip Holdings, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,541,613 | Isoflavone derivatives Term ended Term ended Dec 15, 2020 · USPTO record | Term ended | Term ended Dec 15, 2020 | USPTO record |
| US 6,362,234 | Water-soluble prodrugs of propofol for treatment of migrane Formerly held Term ended Term ended Aug 15, 2020 · USPTO record | Term ended | Term ended Aug 15, 2020 | USPTO record |
| US 6,254,853 | Water soluble pro-drugs of propofol Formerly held Term ended Term ended May 8, 2018 · USPTO record | Term ended | Term ended May 8, 2018 | USPTO record |
| US 4,985,465 | Method for inhibiting viral and retroviral infections Term ended Term ended no later than Jan 15, 2011 · Low confidence | Term ended | Term ended no later than Jan 15, 2011 | Low confidence |
| US 5,114,957 | Tocopherol-based antiviral agents and method of using same Term ended Term ended no later than May 19, 2012 · Low confidence | Term ended | Term ended no later than May 19, 2012 | Low confidence |
| US 5,981,603 | Antiviral agents Term ended Term ended no later than Nov 9, 2019 · Low confidence | Term ended | Term ended no later than Nov 9, 2019 | Low confidence |